Q86WV6 (STING_HUMAN) Homo sapiens (Human)
Stimulator of interferon genes protein UniProtKBInterProSTRINGInteractive Modelling
379 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
93 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of human STING in complex with 3',3'-c-di-(2'F,2'd<carba>AMP) |
Heteromer Q12306; | 99.45 | 1×K43; | |||
| Phosphorylated STING in complex with IRF-3 CTD |
Heteromer Q14653; | 95.24 | ||||
| Crystal structure of STING CTT in complex with TBK1 |
Heteromer Q9WUN2; | 100 | 2×BX7; | |||
| Crystal structure of STING CTD in complex with TBK1 |
Heteromer Q9UHD2; | 72.73 | 2×BX7; | |||
| phospho-STING binding to adaptor protein complex-1 |
Heteromer P22892; P35585; P84077; Q10567; Q96PC3; | 100 | 2×GTP; 2×MG; | |||
| Structure of Stimulator of interferon genes/ligand complex | homo-8-mer | 99.69 | 4×1SY; | |||
| Human STING bound to both cGAMP and 1-[(2-chloro-6-fluorophenyl)methyl]-3,3-dimethyl-2-oxo-N-[(2,4,… | homo-4-mer | 99.69 | 2×9IM; 2×1SY; | |||
| Cryo-EM structure of STING oligomer bound to cGAMP and NVS-STG2 | homo-4-mer | 99.69 | 2×1SY; 2×Y6H; | |||
| Cryo-EM structure of STING oligomer bound to cGAMP, NVS-STG2 and C53 | homo-4-mer | 99.69 | 2×Y6H; 2×1SY; 2×9IM; | |||
| Structure of STING SAVI-related mutant V147L | homo-2-mer | 99.68 | ||||
| Cryo-EM structure of full-length human STING in the apo state | homo-2-mer | 100.0 | ||||
| human STING With agonist HB3089 | homo-2-mer | 100.0 | 1×WJ6; | |||
| Crystal structure of ligand free human STING CTD | homo-2-mer | 99.48 | 2×CA; | |||
| Crystal structure of human STING CTD complex with C-di-GMP | homo-2-mer | 99.48 | 2×CA; 1×C2E; | |||
| human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-[(2-naphthyloxy)methyl]phenyl)-AMP | homo-2-mer | 99.47 | 1×KXD; | |||
| Crystal structure of STING CTD complex with c-di-GMP | homo-2-mer | 100.0 | 1×C2E; 2×CA; | |||
| human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-(2-naphthyl)phenyl)-AMP | homo-2-mer | 99.47 | 1×KWF; | |||
| Crystal structure of STING CTD | homo-2-mer | 100.0 | ||||
| amidobenzimidazole (ABZI) STING agonists | homo-2-mer | 100.0 | 2×CA; 2×HGJ; | |||
| Linked amidobenzimidazole STING agonist | homo-2-mer | 100.0 | 1×HG4; 2×CA; | |||
| Crystal structure of hSTING with an agonist (SHR169224) | homo-2-mer | 100.0 | 2×CA; 2×GD2; | |||
| Crystal structure of hSTING with the agonist, SHR171032 | homo-2-mer | 100.0 | 2×CA; 1×GC0; | |||
| Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-2'd<carba>GMP) | homo-2-mer | 99.46 | 1×JLU; | |||
| Human REF STING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)] | homo-2-mer | 100.0 | 1×GOL; 1×PWB; | |||
| Crystal structure of STING complex with Cyclic di-GMP. | homo-2-mer | 100.0 | 1×C2E; | |||
| human STING in complex with 2',3'-cyclic-GMP-7-deazaphenyl-AMP | homo-2-mer | 99.45 | 1×OK6; | |||
| ERIS/STING in complex with ligand | homo-2-mer | 98.94 | 1×C2E; 2×MG; | |||
| human STING with diABZI agonist 15 | homo-2-mer | 100.0 | 2×WWU; | |||
| Crystal structure of human wild type STING in complex with 2'-3'-cyclic-GMP-7-deaza-AMP | homo-2-mer | 99.47 | 1×KT2; | |||
| human STING in complex with 2'-3'-cyclic-GMP-7-deaza(4-biphenylyl)-AMP | homo-2-mer | 99.46 | 1×KWO; | |||
| Crystal structure of human STING complexed with compound BSP16 | homo-2-mer | 100.0 | 2×A9X; | |||
| Human wtSTING in complex with 3',3'-c-di-AMP | homo-2-mer | 99.44 | 2×2BA; | |||
| hSTING mutant R232K in complex with 2',3'-cGAMP | homo-2-mer | 99.44 | 2×1SY; | |||
| human STING with agonist XMT-1616 | homo-2-mer | 100.0 | 2×WX8; | |||
| Crystal structure of ERIS/STING | homo-2-mer | 98.92 | 2×EPE; | |||
| Crystal structure of human STING complexed with compound BSP17 | homo-2-mer | 100.0 | 2×A8A; | |||
| Crystal structure of STING in complex with cGAMP | homo-2-mer | 99.45 | 2×1SY; | |||
| Crystal structure of human STING in complex with 3'2'-cGAMP | homo-2-mer | 99.44 | 2×4UR; | |||
| Crystal structure of human STING ectodomain in complex with BI 7446, a potent cyclic dinucleotide S… | homo-2-mer | 99.45 | 2×W78; | |||
| Structure of hSTING in complex with novel carbocyclic pyrimidine CDN-2 | homo-2-mer | 99.45 | 2×X5D; | |||
| Structure of hSTING in complex with novel carbocyclic pyrimidine CDN 1 | homo-2-mer | 99.45 | 2×X5J; | |||
| Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING | homo-2-mer | 100.0 | ||||
| Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-<carba>IMP) | homo-2-mer | 99.42 | 1×K1L; | |||
| Crystal structure of human STING in complex with 3',3'-c-(2'dAMP-2'F,2'd<carba>AMP) | homo-2-mer | 99.43 | 2×KAX; | |||
| Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP(S)-2'F,2'd<carba>AMP(S)) | homo-2-mer | 99.43 | 2×KZA; | |||
| Structure of hSTING in complex with novel carbocyclic pyrimidine CDN-3 | homo-2-mer | 99.44 | 2×X4M; | |||
| Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(2',5')p] | homo-2-mer | 100.0 | 1×PO4; 1×1YC; | |||
| Human Stimulator of Interferon Genes | homo-2-mer | 98.87 | 2×2BA; 2×IMD; 2×GOL; | |||
| hSTING in complex with 3',3'-c-di-araAMP | homo-2-mer | 99.44 | 2×V7E; | |||
| Crystal structure of human STING in complex with MD1193 | homo-2-mer | 99.44 | 2×98F; | |||
| Human wtSTING in complex with 3',3'-c-(2'FdAMP-2'FdAMP) | homo-2-mer | 99.44 | 2×M8T; | |||
| Crystal structure of STING REF variant in complex with E7766 | homo-2-mer | 100.0 | 1×V5V; 6×EDO; | |||
| Human wtSTING in complex with 3',3'-cGAMP | homo-2-mer | 99.43 | 2×4BW; | |||
| Crystal Structure of human STING bound to c-di-GMP | homo-2-mer | 100.0 | 1×C2E; 1×CA; | |||
| Crystal structure of human STING apoprotein (G230A, H232R, R293Q) | homo-2-mer | 99.41 | 1×CA; | |||
| Crystal Structure of Human STING CTD complex with SR-717 | homo-2-mer | 99.43 | 2×V67; 2×GOL; 1×EDO; | |||
| Crystal structure of ligand free human STING | homo-2-mer | 100.0 | 1×CA; | |||
| Crystal structure of STING CTD in complex with BDW-OH | homo-2-mer | 98.33 | 2×YGI; | |||
| Crystal structure of STING CTD in complex with 2'3'-cGAMP | homo-2-mer | 98.31 | 2×1SY; | |||
| Crystal structure of hSTING(H232) in complex with c[G(2',5')pA(3',5')p] | homo-2-mer | 100 | 1×1SY; | |||
| Crystal structure of human STING in complex with 3',3'-c-(2'F,2'dAMP-2'F,2'd<carba>AMP) | homo-2-mer | 99.41 | 2×K1C; | |||
| Structure of human STING in complex with MK-1454 | homo-2-mer | 98.32 | 2×ZEV; | |||
| Crystal structure of STING in complex with E7766 | homo-2-mer | 99.42 | 1×V5V; | |||
| Human wtSTING in complex with 3',3'-c-[2'FdAMP-2'FdAM(PS)] | homo-2-mer | 99.42 | 2×PWB; | |||
| Crystal structure of human STING in complex with 3'3'-c-(2'F,2'dA-isonucA)MP | homo-2-mer | 99.43 | 2×8SC; | |||
| Structure of the human STING receptor bound to 2'3'-cUA | homo-2-mer | 99.42 | 1×ZNT; | |||
| Human wtSTING in complex with 3'3'-c-di-GMP | homo-2-mer | 99.42 | 1×C2E; | |||
| Human wtSTING in complex with 2',2'-difluoro-3',3'-c-di-GMP | homo-2-mer | 99.42 | 2×GGF; | |||
| Crystal structure of human wild type STING in complex with 2'3'-cyclic-GMP-2'F-2'dAMP | homo-2-mer | 99.42 | 2×KT8; | |||
| Crystal structure of human STING in complex with the agonist MD1203 | homo-2-mer | 99.43 | 2×VZ6; | |||
| Crystal structure of human STING in complex with the agonist MD1202D | homo-2-mer | 99.44 | 2×WY8; | |||
| Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 1 | homo-2-mer | 99.38 | 2×K5P; 1×CA; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 6 | homo-2-mer | 98.26 | 1×QBG; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 9 | homo-2-mer | 98.27 | 2×QB1; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 11 | homo-2-mer | 98.27 | 1×QBA; | |||
| Human Stimulator of Interferon Genes | homo-2-mer | 98.84 | 2×1SY; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 10 | homo-2-mer | 98.25 | 2×QB7; | |||
| Crystal structure of hSTING in complex with c[2',3'-(ribo-2'-G, xylo-3'-A)-MP](RJ244) | homo-2-mer | 100.0 | 1×9UR; | |||
| Crystal structure of hSTING in complex with c[2',3'-(ara-2'-G, ribo-3'-A)-MP] (RJ242) | homo-2-mer | 100.0 | 2×9UH; | |||
| Stimulator of Interferon Genes Human | homo-2-mer | 99.41 | 2×2BA; | |||
| Human wtSTING in complex with 2',2'-difluoro-3',3'-cGAMP | homo-2-mer | 99.42 | 2×OOE; | |||
| WT STING in complex with 3',3'-c-di[2'FdAM(PS)] | homo-2-mer | 99.41 | 2×R4T; | |||
| Crystal structure of hSTING(group2) in complex with DMXAA | homo-2-mer | 96.13 | 2×1YE; | |||
| Crystal structure of human STING R232 in complex with compound 11 | homo-2-mer | 99.41 | 2×B7L; | |||
| Crystal structure of hSTING(S162A/G230I/Q266I) in complex with DMXAA | homo-2-mer | 97.79 | 2×1YE; 1×SO4; | |||
| Crystal structure of hSTING(S162A/Q266I) in complex with DMXAA | homo-2-mer | 98.34 | 2×1YE; 1×SO4; | |||
| Crystal structure of human STING (G230A, H232R, R293Q) in complex with Compound 18 | homo-2-mer | 99.39 | 2×K5S; 2×CA; | |||
| Crystal structure of hSTING(G230I) in complex with DMXAA | homo-2-mer | 98.89 | 2×1YE; | |||
| Crystal structure of human STING in complex with ADU-S100 | monomer | 99.44 | 1×GJF; 1×CA; 4×NA; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 12 | monomer | 98.25 | 1×QBD; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 3 | monomer | 98.31 | 1×QAV; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound MSA-2 | monomer | 98.29 | 1×QAD; | |||
| STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 4 | monomer | 98.3 | 1×QBJ; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8flk.1.A | homo-4-mer | 0.73 | 2×Y6H; | 99.71 | ||
| 8gsz.1.A | homo-2-mer | 0.66 | 99.74 | |||